Patents by Inventor Ulrike Spohr

Ulrike Spohr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified kojibioside analogues
    Patent number: 5877157
    Abstract: Disclosed are novel analogues of kojibiose and pharmaceutical compositions comprising such analogues.
    Type: Grant
    Filed: March 7, 1997
    Date of Patent: March 2, 1999
    Assignee: Alberta Research Council
    Inventors: Om Srivastava, Roman Szweda, Ulrike Spohr
  • Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen
    Patent number: 5814616
    Abstract: The present invention is directed to methods of reducing the degree of inflammation arising from a secondary immune response in a mammal due to antigen exposure (challenge) by the administration of valienamine-related disaccharide compounds and the pharmaceutical compositions employed in the method.
    Type: Grant
    Filed: November 5, 1996
    Date of Patent: September 29, 1998
    Assignee: Alberta Research Council
    Inventors: Om P. Srivastava, Roman Szweda, Richard H. Smith, Robert M. Ippolito, Ulrike Spohr
  • Modified kojibiosides analogues
    Patent number: 5633233
    Abstract: Disclosed are novel analogues of kojibiose and pharmaceutical compositions comprising such analogues.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 27, 1997
    Assignee: Alberta Research Council
    Inventors: Om Srivastava, Roman Szweda, Ulrike Spohr
  • Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen
    Patent number: 5571796
    Abstract: The present invention is directed to methods of reducing the degree of inflammation arising from a secondary immune response in a mammal due to antigen exposure (challenge) by the administration of valienamine-related disaccharide compounds and the pharmaceutical compositions employed in the method.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 5, 1996
    Assignee: Alberta Research Council
    Inventors: Om P. Srivastava, Roman Szweda, Richard H. Smith, Robert M. Ippolito, Ulrike Spohr